|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 |
| (11) | Number of the document | 2361617 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11161473.1 |
| Date of filing the European patent application | 2005-04-21 | |
| (97) | Date of publication of the European application | 2011-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 836880 | 2004-04-30 | US |
| (72) |
Huang, Glenn T., US
Nivaggioli, Thierry, US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies |
| Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies |